Measures endorsed by the European Parliament in plenary intended to help the EU better manage future health crises through addressing medical device and medicines shortages more effectively, will give the European Medicines Agency a greater role in overseeing devices.
The parliament voted in favor of a text setting out these new responsibilities for the EMA on 20 January, in plenary, by 655 votes to 31, with eight abstentions, thereby endorsing the provisional agreement reached with the Council last year